Circulating tumor DNA sequencing of gastroesophageal adenocarcinoma.

PURPOSE: Gastroesophageal adenocarcinoma (GEA) has a poor prognosis and few therapeutic options. Utilizing a 73-gene plasma-based next-generation sequencing (NGS) cell-free circulating tumor DNA (ctDNA-NGS) test, we sought to evaluate the role of ctDNA-NGS in guiding clinical decision-making in GEA....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Maron, Steven B., Chase, Leah M., Lomnicki, Samantha, Kochanny, Sara, Moore, Kelly L., Joshi, Smita S., Landron, Stacie, Johnson, Julie, Kiedrowski, Lesli A., Nagy, Rebecca J., Lanman, Richard B., Kim, Seung Tae, Lee, Jeeyun, Catenacci, Daniel V.T.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891164/
https://ncbi.nlm.nih.gov/pubmed/31427281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1704
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items